01 — What is it?
Somatropin is recombinant human growth hormone with established medical uses including selected pediatric growth disorders and adult growth-hormone deficiency, depending on product and label.
Database / Research Profiles / HGH / Somatropin
RESEARCH PROFILE
HGH / SOMATROPIN
Recombinant human growth hormone
EndocrinologyApproved therapeutic with specific indications
EVIDENCE SNAPSHOTAPPROVED THERAPEUTIC WITH SPECIFIC INDICATIONS
Approved indications do not establish benefit for general anti-aging, bodybuilding or performance use.
Research-first: This profile summarizes published evidence and regulatory context. It is educational reference material, not a diagnosis, treatment recommendation, or personalized dosing protocol.
02 — Research category
Endocrinology. Evidence strength is based on the availability and quality of human clinical data, not on popularity in the research-peptide market.
03 — Evidence map
Human evidence: YESPreclinical evidence: SUPPLEMENTALPersonal dosing protocol: NOT PROVIDED
Approved indications do not establish benefit for general anti-aging, bodybuilding or performance use.
04 — Mechanism / biology
Somatropin is recombinant human growth hormone with established medical uses including selected pediatric growth disorders and adult growth-hormone deficiency, depending on product and label.
05 — Safety & limitations
Safety depends on the exact molecule, formulation, route, dose, indication and study population. Research-market products may differ in identity, purity, sterility or stability from materials used in published trials. Absence of reported adverse events in a small study does not establish long-term safety.
06 — Regulatory context
Regulatory status varies by compound and jurisdiction. Where an approved product exists, its approval applies only to specified formulations and indications. Investigational or research-market status should not be presented as equivalent to approval.